Evidence map›Paper›PMID 34338833›Full record

ArticleCurrent microbiology2021

Design and Evaluation of Multiplex One-Step Reverse Transcription PCR-Dipstick Chromatography Method for the Analysis of Seven Respiratory Pathogens.

Li Luo, Qianming Chen, Sheng Qin, Qiang Luo, Zhenjie Liu, Qiong Li, Shuilan Zheng, Xianzhang Huang, Peifeng Ke, Xiangsheng Yang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Establishment and Performance Evaluation of Multiplex PCR-Dipstick DNA Chromatography forThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Li LuoSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Qianming ChenSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Sheng QinSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Qiang LuoSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Zhenjie LiuSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Qiong LiResearch and Development Department, Zone C, Science and Technology Innovation Base, Guangzhou Biotron Technology Co. Ltd, Room 204, No. 80, Lanyue Road, Science City, Guangzhou, 510000, China.
Shuilan ZhengDepartment of Laboratory Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Xianzhang HuangSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Peifeng KeSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Xiangsheng YangResearch and Development Department, Zone C, Science and Technology Innovation Base, Guangzhou Biotron Technology Co. Ltd, Room 204, No. 80, Lanyue Road, Science City, Guangzhou, 510000, China.
Hui XiaoResearch and Development Department, Zone C, Science and Technology Innovation Base, Guangzhou Biotron Technology Co. Ltd, Room 204, No. 80, Lanyue Road, Science City, Guangzhou, 510000, China. hui-xiao@ebiotron.com.
Ning XuSecond School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. xu_ning21@126.com.ORCID http://orcid.org/0000-0002-2926-9607
Guangzhou University of Chinese Medicine · CNBio-Medical Science (South Korea) · KR

Funding

Chinese Medicine Science and Technology Research Project of Guangdong Provincial Hospital of Chinese Medicine YN2019QL05guangzhou science and technology plan project 202002020038guangzhou science and technology plan project 202103000025
6 · The paper itself

Abstract

Influenza A, influenza B, severe acute respiratory syndrome coronavirus 2, adenovirus, respiratory syncytial virus, Mycoplasma pneumoniae, and Chlamydophila pneumoniae are common pathogens that can cause severe pneumonia and other symptoms, resulting in acute lower respiratory tract infections. The objective of this study was to design and evaluate a sensitive and specific multiplex one-step reverse transcription PCR (RT-PCR)-dipstick chromatography method for simultaneous rapid detection of these seven pathogens. Streptavidin-coated blue latex particles were used to read out a positive signal. Based on the DNA-DNA hybridization of oligonucleotide sequences (Tag) for forward primer with the complementary oligonucleotide sequence (cTag) on the dipstick and biotin-streptavidin interactions, PCR products were able to be illuminated visually on the dipstick. The specificity and the limit of detection (LOD) were also evaluated. Moreover, the clinical performance of this method was compared with Sanger sequencing for 896 samples. No cross reaction with other pathogens was found, confirming the high specificity of this method. The LOD was 10 copies/µL for each of the tested pathogens, and the whole procedure took less than 40 min. Using 896 samples, the sensitivity and specificity were shown to be no lower than 94.5%. The positive predictive value was higher than 82.1%, and the negative predictive value was higher than 99.5%. The kappa value between the PCR-dipstick chromatography method and Sanger sequencing ranged from 0.869 to 0.940. In summary, our one-step RT-PCR-dipstick chromatography method is a sensitive and specific tool for rapidly detecting multiplex respiratory pathogens.

Indexed as

COVID-19Reverse TranscriptionChromatographyHumansMultiplex Polymerase Chain ReactionSARS-CoV-2Sensitivity and Specificity

Identifiers

PMID34338833
PMCPMC8326646
OpenAlexW3191804398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.